Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Global Phase 1 study of CLN-978 in systemic lupus erythematosus (SLE) cleared to initiate in U.S. and Australia; initial ...
The Citizen2d
Man arrested in Cullinan for possession of drugs, ammo
Police in Cullinan arrested a 46-year-old man in possession of ammunition and drugs on Saturday. Police spokesperson Sergeant ...
autoevolution2d
You Hit What? Truck Collides With Rolls-Royce Cullinan in Central London
A Rolls-Royce Cullinan is now deformed after a third-degree encounter with a lorry truck. Nobody knows who is to blame for ...
Rolls-Royce sales in Russia booming - data
Rolls-Royce sales in Russia jumped by almost 40 between January and September according to Auto Mail Read Full Article at ...
Yahoo Finance2d
Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today ...
autoevolution3d
Novitec Puts New Running Shoes on the Facelifted Rolls-Royce Cullinan
This 2025 Rolls-Royce Cullinan features new wheels that Novitec and Vossen co-developed. Is it the luxury SUV of your dreams?
Cullinan Management: Strong Financials and Promising Pipeline Drive Buy Rating
Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Cullinan Management (CGEM – Research Report). The associated ...
Sunday Times Driving6d
Rolls-Royce Cullinan II 2024 review: Makes a statement ... but is it the right one?
Whether you love or hate the Rolls-Royce Cullinan and everything it stands for, there’s no denying its success. So, will the ...